The future of neuromodulatory treatments & psychedelic-assisted therapies holds immense promise in revolutionizing mental health treatment. Through rigorous research and growing acceptance, treatments like TMS, Ketamine, psilocybin, MDMA, and LSD are being recognized for their potential to alleviate conditions such as depression, anxiety, PTSD, and addiction.  As clinical trials continue to demonstrate their safety and efficacy, we can anticipate a broader integration of these therapies into mainstream healthcare, accompanied by regulations to ensure responsible use and trained practitioners. With ongoing advancements and a shift in societal attitudes, psychedelic-assisted therapies have the potential to offer transformative healing experiences and pave the way for a new era of mental well-being.